16MA023N HDAC, BTK: Method of Using HDAC Inhibitors, Alone or in Combination with BTK Inhibitors, for Treating Chronic Lymphocytic Leukemia (CLL)
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CALL OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828